Estrogen receptor alpha 46 is reduced in tamoxifen resistant breast cancer cells and re-expression inhibits cell proliferation and estrogen receptor alpha 66-regulated target gene transcription

Resistance to endocrine therapy is a major clinical problem in breast cancer. The role of ERα splice variants in endocrine resistance is largely unknown. We observed reduced protein expression of an N-terminally truncated ERα46 in endocrine- resistant LCC2, LCC9, and LY2 compared to MCF-7 breast can...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Klinge, Carolyn M., Riggs, Krista A., Wickramasinghe, Nalinie S., Emberts, Celia G., McConda, David B., Barry, Parul N., Magnusen, Joan E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875375/
https://ncbi.nlm.nih.gov/pubmed/20302909
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2010.03.013
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak